DMK Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	2017 - 1995
Revenue	3.62	4.76	2.21	2.78	22.11	15.09	Upgrade
Revenue Growth (YoY)	134.95%	115.34%	-20.45%	-87.44%	46.58%	15.40%	Upgrade
Cost of Revenue	4.97	6.19	6.87	6.33	15.48	9.8	Upgrade
Gross Profit	-1.35	-1.43	-4.66	-3.55	6.64	5.29	Upgrade
Selling, General & Admin	14.48	13.25	16.14	20.09	25.29	25.95	Upgrade
Research & Development	2.97	10.38	11.26	8.04	10.38	18.79	Upgrade
Other Operating Expenses	6.54	0	0	4.66	0.32	0.01	Upgrade
Operating Expenses	23.99	23.63	27.41	32.79	35.99	44.75	Upgrade
Operating Income	-25.34	-25.06	-32.07	-36.34	-29.35	-39.46	Upgrade
Interest Expense / Income	-0.35	-0.04	0.01	0	0.12	0.16	Upgrade
Other Expense / Income	-2.76	1.46	13.75	13.04	-1.97	-0.25	Upgrade
Pretax Income	-22.23	-26.48	-45.83	-49.39	-27.5	-39.38	Upgrade
Income Tax	0	0	0	0	0.01	-0.37	Upgrade
Net Income	-22.23	-26.48	-45.83	-49.39	-27.51	-39.01	Upgrade
Shares Outstanding (Basic)	7	2	2	1	1	1	Upgrade
Shares Outstanding (Diluted)	7	2	2	1	1	1	Upgrade
Shares Change	229.77%	3.95%	85.84%	45.63%	36.28%	37.87%	Upgrade
EPS (Basic)	-9.90	-12.60	-22.40	-44.80	-36.40	-70.00	Upgrade
EPS (Diluted)	-9.90	-12.60	-22.40	-44.80	-36.40	-70.00	Upgrade
Free Cash Flow	-9.47	-26.58	-39.01	-21.35	-22.75	-36.19	Upgrade
Free Cash Flow Per Share	-1.34	-12.42	-18.94	-19.27	-29.90	-64.82	Upgrade
Gross Margin	-37.30%	-30.10%	-211.14%	-127.87%	30.00%	35.06%	Upgrade
Operating Margin	-700.02%	-526.88%	-1451.97%	-1308.89%	-132.72%	-261.58%	Upgrade
Profit Margin	-614.21%	-556.72%	-2074.91%	-1778.84%	-124.41%	-258.55%	Upgrade
Free Cash Flow Margin	-261.54%	-558.88%	-1766.16%	-769.00%	-102.89%	-239.90%	Upgrade
EBITDA	-21.94	-25.04	-44.39	-47.05	-24.42	-36.12	Upgrade
EBITDA Margin	-606.19%	-526.42%	-2009.57%	-1694.69%	-110.42%	-239.41%	Upgrade
Depreciation & Amortization	0.64	1.48	1.44	2.33	2.96	3.1	Upgrade
EBIT	-22.58	-26.52	-45.82	-49.38	-27.38	-39.22	Upgrade
EBIT Margin	-623.76%	-557.61%	-2074.58%	-1778.58%	-123.82%	-259.95%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).